covid-19
الرسائل الموجهة للمختصين الصحيين
الرسائل الموجهة للمختصين الصحيين
| المنتج | التاريخ | معلومات السلامة | المرفقات |
|---|---|---|---|
| Esbriet (pirfenidone) | 2020-12-14 | Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI) |
|
| Levon (Levofloxacin Hemihydrate) / Moxiflox (Moxifloxacin) | 2020-11-19 | Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence. |
|
| Tarivid (Ofloxacin) / Tavanic (Levofloxacin) | 2020-11-05 | Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence. |
|
| Revlimid® (Lenalidomide) | 2020-10-21 | Notification of typographical error in the Revlimid® (Lenalidomide) Hard Capsules Patient Information Leaflet (PIL) |
|
| Motilium (Domperidone) | 2020-10-18 | Removal of the paediatric posology and reminder of indication and contraindications related to serious cardiac side-effects |
|
| Levofloxacin Sandoz (Levofloxacin) | 2020-09-13 | Systemic fluoroquinolones: risk of heart valve regurgitation |
|
| Hydrochlorothiazide | 2020-08-24 | Hydrochlorothiazide - Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) |
|
| Co-olmepress / Co-cinfaval | 2020-08-19 | Hydrochlorothiazide - Risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) |
|
| Curacne (Isotretinoin) | 2020-08-19 | Isotretinoin - update on teratogenicity and neuropsychiatric disorders |
|
| 5-Fluorouracil Capecitabine | 2020-07-27 | 5-Fluorouracil (i.v.) and capecitabine containing products: Pre-treatment testing to identify DPD-deficient patients at increased risk of severe toxicity. |
|